Drug
Rifapentine clinical trials
Also written Priftin.
Keep track of what changes. Save the rifapentine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Priftin
- 13
Studies by the year they started
45 studies that test it; most in 2016 (4)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 3 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 44
Centers for Disease Control and Prevention (9) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Johns Hopkins University (6) · The Aurum Institute NPC (2) · National Taiwan University Hospital (2) · Huashan Hospital (2) · Kaohsiung Veterans General Hospital. (1) · Yale University (1)
Often tested with
Tested in the same studies.
Isoniazid (14) · Moxifloxacin (7) · Ethambutol (2) · Clofazimine (2) · Levofloxacin (2) · Bedaquiline (2) · Rifampin (2) · Pyrazinamide (2)
Studies
Open first, then newest update. How each study uses rifapentine is read from its arms, and is right about nine times in ten.
Testing it · 46
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)Not yet recruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT07595042Written as Rifapentine
- Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB PreventionRecruitingPhase 1Brigham and Women's HospitalNCT06281834Written as Rifapentine
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingPhase 3Johns Hopkins UniversityNCT06253715Written as Rifapentine
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)RecruitingPhase 3Huashan HospitalNCT06022146Written as isoniazid and rifapentine
- Shorter and Safer Treatment Regimens for Latent TBRecruitingPhase 2/3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06498414Written as levofloxacin and rifapentine
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBIRecruitingPhase 2/3Centers for Disease Control and PreventionNCT03474029Written as Rifapentine daily for 6 weeks
- Short-Course Anti-tuberculosis Regimens for Mild Spinal TuberculosisNot yet recruitingPhase 2Shandong UniversityNCT06917495Written as Rifapentine (RPT)
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney DiseaseNot yet recruitingPhase 4Miguel SantínNCT05021731Written as Rifapentine plus Isoniazid
- Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes MellitusRecruitingPhase 3Dr. Nyanda Elias NtinginyaNCT04600167Written as Isoniazid and Rifapentine (INH-RPT)
- Sitafloxacin-containing Regimens for Shortening Tuberculosis TreatmentNot yet recruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT05454345Written as Rifapentine
- 1HP Versus 3HR in the Treatment of Tuberculosis Infection in VietnamWithdrawnPhase 3Freundeskreis Für Internationale Tuberkulosehilfe e.VNCT06191692Written as Rifapentine
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of TuberculosisCompletedPhase 3Centers for Disease Control and PreventionNCT02563327Written as Rifapentine
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) TreatmentCompletedPhase 2Centers for Disease Control and PreventionNCT00694629Written as rifapentine
- Tuberculosis Clinical Trials Consortium Study 35CompletedPhase 1/2Centers for Disease Control and PreventionNCT03730181Written as Rifapentine
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyTerminatedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT04311502Written as Rifapentine
- TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB InfectionCompletedNot applicableCenters for Disease Control and PreventionNCT00164450Written as Rifapentine
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsCompletedNot applicableYale UniversityNCT03089983Written as Rifapentine
- Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIVActive, not recruitingPhase 1/2The Aurum Institute NPCNCT05122026Written as Rifapentine
- Ultra Curto (Ultra Short) TB Prevention TherapyCompletedPhase 4Johns Hopkins UniversityNCT04703075Written as Rifapentine 600 mg and INH 300 mg
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening RegimensCompletedPhase 3Centers for Disease Control and PreventionNCT02410772Written as rifapentine
See all 46 studies that test rifapentine →
Given in every arm · 2 — rifapentine is usual care beside what is tested
- A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIVRecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT07124559Written as Rifapentine
- Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOTCompletedPhase 3Centers for Disease Control and PreventionNCT01582711Written as isoniazid and rifapentine
As the comparator · 1 — what is tested is compared with rifapentine
Codes
What other systems call rifapentine · ClinicalTrials.gg INT002698
- MeSH (NLM) C018421rifapentineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) XJM390A33URIFAPENTINEConfirmed FDA, NLM, Wikidata
- RxNorm 35617Confirmed FDA, Wikidata
- Wikidata Q3935297rifapentineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66516RifapentineOne source FDA
- DrugBank DB01201One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C018421 | rifapentine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | XJM390A33U | RIFAPENTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 35617 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3935297 | rifapentine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66516 | Rifapentine | One source FDA |
| DrugBank | DB01201 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.